Inova Translational Medicine Institute (ITMI)
    Research facility
    
    
        Location: 
        Annandale,
        
                United States (USA) (US)
                
    
        
    
    
    
    
    
    
    
        
    
        
    
        
    
    
    
        
            
                
  
  miR-155 harnesses Phf19 to potentiate cancer immunotherapy through epigenetic reprogramming of CD8+ T cell fate (2019)
  Ji Y, Fioravanti J, Zhu W, Wang H, Wu T, Hui J, Lacey NE, et al.
  Journal article
            
                
  
  The transcription factor c-Myb regulates CD8+T cell stemness and antitumor immunity (2019)
  Gautam S, Fioravanti J, Zhu W, Le Gall JB, Brohawn P, Lacey NE, Hu J, et al.
  Journal article